WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Gilead continues to feast on tens of billions ... include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed ...

Gilead Sciences received approval from the Food ... include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not ...

Eyes on Gilead is an SBS Australia production. We acknowledge the Traditional Owners of Country throughout Australia, and Eyes On Gilead Live was recorded on the lands of the Gadigal people of the ...

Gilead did not respond to a request for comment ... to both the industry and the US government, there is a third party that has a significant interest and stake in the case: the people needing ...

Aisera, a leading provider of agentic AI for business, today announced a major expansion of its award-winning Agentic AI platform, introducing a new comprehensive System of AI Agents designed to ...

Partnership combines AbTherx's proprietary Atlas™ Long CDR3 Technology with GPCR Therapeutics' deep expertise in GPCR biology to discover and develop antibodies for novel targets MOUNTAIN VIEW, ...

The United States has given its approval to the world’s first twice-a-year injection for HIV prevention, marking a ...

Here’s what to know about the twice-yearly preventative HIV shot - A twice-yearly drug called lenacapavir is now the ...

Get ready to check out some books, create art, listen to music, and maybe even have some fun during Perry Cook Memorial Library’s annual summer reading program.

The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...

Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the ...